Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease

Journal of General Virology

Volumn 89, Issue 4, 2008, Pages 910-914

  Mbulawa, Zizipho Z A ^a,b   Williamson, Anna Lise ^a,b   Stewart, Debbie ^a   Passmore, Jo Ann S ^a   Denny, Lynette ^a   Allan, Bruce ^a   Marais, Dianne J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VERRUCA VULGARIS; VIRUS NEUTRALIZATION; AFRICA; CLASSIFICATION; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; MUCOSA; SERODIAGNOSIS; SOUTH AFRICA; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIRUS INFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADULT; AFRICA; ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MUCOUS MEMBRANE; NEUTRALIZATION TESTS; PAPILLOMAVIRUS INFECTIONS; SOUTH AFRICA; UTERINE CERVICAL DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 45549087250     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83458-0     Document Type: Article

References (18)

1. Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M. & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55, 244-265.
2. de Gruijl, T. D., Bontkes, H. J., Walboomers, J. M. M., Coursaget, P., Stukart, M. J., Dupuy, C., Kueter, E., Verheijen, R. H. M., Helmerhorst, T. J. M. & other authors (1999). Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome. J Gen Virol 80, 399-408.
3. Gross, G. & Pfister, H. (2004). Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 193, 35-44.
4. Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A. B., Romonowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Clemens, S. A. C. & other authors (2006). Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367, 1247-1255.
5. Kawana, K., Yasugi, T., Kanda, T., Kawana, Y., Hirai, Y., Yoshikawa, H. & Taketani, Y. (2002). Neutralizing antibodies against oncogenic human papillomavirus as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia. Biochem Biophys Res Commun 296, 102-105.
6. Lowy, D. R. & Schiller, J. T. (2006). Prophylactic human papillomavirus vaccines. J Clin Invest 116, 1167-1173.
7. Marais, D., Rose, R. C. & Williamson, A. L. (1997). Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa. J Med Virol 51, 126-131.
8. Marais, D. J., Best, J. M., Rose, R. C., Keating, P., Soeters, R., Denny, L., Dehaeck, C. M. C., Nevin, J., Kay, P. & other authors (2001). Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia 1. J Med Virol 65, 149-154.
9. Marais, D. J., Sampson, C., Jeftha, A., Dhaya, D., Passmore, J.-A. S., Denny, L., Rybicki, E. P., Van Der Walt, E., Stephen, L. X. G. & Williamson, A.-L. (2006). More men than women make mucosal IgA antibodies to human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis 6, 1471.
10. Mqoqi, N., Kellet, P., Sitas, F. & Musa, J. (2004). Incidence of Histologically Diagnosed Cancer in South Africa, 1998-1999. Johannesburg: National Cancer Registry of South Africa.
11. Pagliusi, S. R., Dillner, J., Pawlita, M., Quint, W. G. V., Wheeler, C. M. & Ferguson, M. (2006). Chapter 23: International Standard reagents for harmonization of HPV serology and DNA assays - an update. Vaccine 24, S193-200.
12. Pastrana, D. V., Buck, C. E., Pang, Y. Y. S., Thompson, C. D., Castle, P. E., FitzGerald, P. C., Kjaer, S. K., Lowy, D. R. & Schiller, J. T. (2004). Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321, 205-216.
13. Rudin, A., Johansson, E. L., Bergquist, C. & Holmgren, J. (1998). Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect Immun 66, 3390-3396.
14. Sonnex, C. (1998). Influence of ovarian hormones on urogenital infection. Sex Transm Infect 74, 11-19.
15. Viscidi, R. P., Ahdieh-Grant, L., Clayman, B., Fox, K., Massad, L. S., Cu-Uvin, S., Shah, K. V., Anastos, K. M., Squires, K. E. & other authors (2003). Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis 187, 194-205.
16. Viscidi, R. P., Snyder, B., Cu-Uvin, S., Hogan, J. W., Clayman, B., Klein, R. S., Sobel, J. & Shah, K. V. (2005). Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev 14, 283-288.
17. Walboomers, J. M. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J. F., Peto, J., Meijer, C. J. L. M. & Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19.
18. White, W. I., Wilson, S. D., Bonnez, W., Rose, R. C., Koenig, S. & Suzich, J. A. (1998). In vitro infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol 72, 959-964.